trending Market Intelligence /marketintelligence/en/news-insights/trending/3MDOrXzfpKtpVME_UdlWJA2 content esgSubNav
In This List

Suda raises A$1.5M in underwritten placement

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Suda raises A$1.5M in underwritten placement

Suda Ltd. raised A$1.5 million in an oversubscribed underwritten placement of 75 million fully paid ordinary shares at 2 Australian cents apiece.

The company will use the funds to commercialize and further develop its drug pipeline, which includes ZolpiMist for the treatment of insomnia.

RM Corporate Finance acted as the lead manager and underwriter of the placement.

As of April 6, US$1 was equivalent to A$1.32.